دورية أكاديمية

Essential role of the CCL2-CCR2 axis in Mayaro virus-induced disease.

التفاصيل البيبلوغرافية
العنوان: Essential role of the CCL2-CCR2 axis in Mayaro virus-induced disease.
المؤلفون: Santos FM; Department of Morphology, Drug Research and Development Center, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil., Costa VRdM; Department of Morphology, Drug Research and Development Center, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil., Araújo Sd; Department of Physiology and Biophysics, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil., Sousa CDFd; Department of Microbiology, Host Microorganism Interaction Laboratory, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil., Moreira TP; Department of Microbiology, Host Microorganism Interaction Laboratory, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil., Gonçalves MR; Department of Morphology, Drug Research and Development Center, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil., Santos ACPMd; Department of Microbiology, Host Microorganism Interaction Laboratory, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil., Ferreira HAS; Department of Physiology and Biophysics, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil., Costa PAC; Department of Physiology and Biophysics, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil., Barrioni BR; Department of Metallurgical and Materials Engineering, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil., Bargi-Souza P; Department of Physiology and Biophysics, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil., Pereira MdM; Department of Metallurgical and Materials Engineering, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil., Nogueira ML; Virology Research Laboratory, São José do Rio Preto School of Medicine (FAMERP), São José do Rio Preto, São Paulo, Brazil., Souza DdG; Department of Microbiology, Host Microorganism Interaction Laboratory, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil., Guimarães PPG; Department of Physiology and Biophysics, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil., Teixeira MM; Department of Biochemistry and Immunology, Drug Research and Development Center, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil., Queiroz-Junior CM; Department of Morphology, Drug Research and Development Center, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil., Costa VV; Department of Morphology, Drug Research and Development Center, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.
المصدر: Journal of virology [J Virol] 2024 Jan 23; Vol. 98 (1), pp. e0110223. Date of Electronic Publication: 2024 Jan 03.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: American Society For Microbiology Country of Publication: United States NLM ID: 0113724 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1098-5514 (Electronic) Linking ISSN: 0022538X NLM ISO Abbreviation: J Virol Subsets: MEDLINE
أسماء مطبوعة: Publication: Washington Dc : American Society For Microbiology
Original Publication: Baltimore, American Society for Microbiology.
مواضيع طبية MeSH: Alphavirus Infections*/immunology , Arthritis*/immunology , Arthritis*/virology , Chemokine CCL2*/immunology , Receptors, CCR2*/immunology, Animals ; Mice ; Alphavirus ; Interleukin-6/immunology ; Mice, Inbred C57BL ; Mice, Knockout ; Male ; Bone Diseases/virology
مستخلص: Mayaro virus (MAYV) is an emerging arbovirus member of the Togaviridae family and Alphavirus genus. MAYV infection causes an acute febrile illness accompanied by persistent polyarthralgia and myalgia. Understanding the mechanisms involved in arthritis caused by alphaviruses is necessary to develop specific therapies. In this work, we investigated the role of the CCL2/CCR2 axis in the pathogenesis of MAYV-induced disease. For this, wild-type (WT) C57BL/6J and CCR2 -/- mice were infected with MAYV subcutaneously and evaluated for disease development. MAYV infection induced an acute inflammatory disease in WT mice. The immune response profile was characterized by an increase in the production of inflammatory mediators, such as IL-6, TNF, and CCL2. Higher levels of CCL2 at the local and systemic levels were followed by the significant recruitment of CCR2 + macrophages and a cellular response orchestrated by these cells. CCR2 -/- mice showed an increase in CXCL-1 levels, followed by a replacement of the macrophage inflammatory infiltrate by neutrophils. Additionally, the absence of the CCR2 receptor protected mice from bone loss induced by MAYV. Accordingly, the silencing of CCL2 chemokine expression in vivo and the pharmacological blockade of CCR2 promoted a partial improvement in disease. Cell culture data support the mechanism underlying the bone pathology of MAYV, in which MAYV infection promotes a pro-osteoclastogenic microenvironment mediated by CCL2, IL-6, and TNF, which induces the migration and differentiation of osteoclast precursor cells. Overall, these data contribute to the understanding of the pathophysiology of MAYV infection and the identification future of specific therapeutic targets in MAYV-induced disease.IMPORTANCEThis work demonstrates the role of the CCL2/CCR2 axis in MAYV-induced disease. The infection of wild-type (WT) C57BL/6J and CCR2 -/- mice was associated with high levels of CCL2, an important chemoattractant involved in the recruitment of macrophages, the main precursor of osteoclasts. In the absence of the CCR2 receptor, there is a mitigation of macrophage migration to the target organs of infection and protection of these mice against bone loss induced by MAYV infection. Much evidence has shown that host immune response factors contribute significantly to the tissue damage associated with alphavirus infections. Thus, this work highlights molecular and cellular targets involved in the pathogenesis of arthritis triggered by MAYV and identifies novel therapeutic possibilities directed to the host inflammatory response unleashed by MAYV.
Competing Interests: The authors declare no conflict of interest.
References: PLoS Pathog. 2017 Dec 15;13(12):e1006748. (PMID: 29244871)
J Virol. 2010 Aug;84(16):8021-32. (PMID: 20519386)
Ann Rheum Dis. 2017 May;76(5):914-922. (PMID: 27965260)
BMC Infect Dis. 2013 Aug 08;13:369. (PMID: 23927600)
Emerg Infect Dis. 2013 Nov;19(11):1839-42. (PMID: 24210165)
Emerg Microbes Infect. 2018 Sep 26;7(1):163. (PMID: 30254258)
Osteoarthritis Cartilage. 2017 Jun;25(6):914-925. (PMID: 27856294)
Curr Opin Immunol. 2017 Oct;48:1-6. (PMID: 28738211)
J Immunol. 2015 Nov 1;195(9):4306-18. (PMID: 26401006)
Front Immunol. 2020 Dec 21;11:615327. (PMID: 33408720)
Arthritis Rheum. 2009 Aug;60(8):2513-23. (PMID: 19644852)
Trends Microbiol. 2015 Jan;23(1):35-43. (PMID: 25449049)
Virus Res. 2013 Nov 6;177(2):179-88. (PMID: 24012515)
Emerg Infect Dis. 2016 Apr;22(4):750-2. (PMID: 26981875)
J Infect Dis. 2008 Jun 1;197(11):1585-93. (PMID: 18433328)
PLoS Negl Trop Dis. 2015 Oct 23;9(10):e0004104. (PMID: 26496497)
Nat Rev Immunol. 2011 Oct 10;11(11):762-74. (PMID: 21984070)
Arthritis Rheum. 2012 Feb;64(2):474-84. (PMID: 21952942)
Viruses. 2019 Aug 29;11(9):. (PMID: 31470617)
J Infect Dis. 2012 Aug 1;206(3):455-7: 457-9. (PMID: 22634878)
Nat Biomed Eng. 2020 Nov;4(11):1076-1089. (PMID: 33020600)
Sci Rep. 2017 Mar 24;7(1):421. (PMID: 28341837)
J Virol. 2014 Jun;88(12):6862-72. (PMID: 24696480)
Clin Immunol. 2012 Jul;144(1):57-69. (PMID: 22673491)
J Clin Virol. 2014 Jul;60(3):317-9. (PMID: 24856445)
J Infect Dis. 2011 Oct 1;204(7):1026-30. (PMID: 21881117)
Biomed Res Int. 2013;2013:973516. (PMID: 24069610)
Annu Rev Virol. 2017 Sep 29;4(1):413-427. (PMID: 28637387)
mSphere. 2020 Jun 3;5(3):. (PMID: 32493723)
Brain Behav Immun. 2010 Aug;24(6):919-29. (PMID: 20211719)
Proc Natl Acad Sci U S A. 2011 Jul 19;108(29):12048-53. (PMID: 21730129)
Proc Natl Acad Sci U S A. 2011 Mar 1;108(9):3731-6. (PMID: 21245297)
Proc Natl Acad Sci U S A. 2012 Dec 11;109(50):20602-7. (PMID: 23185004)
Arthritis Res Ther. 2004;6(3):93-7. (PMID: 15142257)
PLoS Negl Trop Dis. 2017 Aug 31;11(8):e0005462. (PMID: 28859086)
Virol J. 2014 Nov 19;11:189. (PMID: 25407789)
J Mol Med (Berl). 2005 Sep;83(9):672-81. (PMID: 15827759)
J Infect Dis. 2015 Jun 15;211(12):1925-35. (PMID: 25635123)
J Leukoc Biol. 1996 Jan;59(1):67-74. (PMID: 8558070)
Bone. 2003 Jan;32(1):1-7. (PMID: 12584029)
J Immunol. 2001 Nov 1;167(9):5381-5. (PMID: 11673556)
Front Endocrinol (Lausanne). 2019 Apr 18;10:236. (PMID: 31057482)
Sci Rep. 2020 Mar 24;10(1):5306. (PMID: 32210270)
Front Immunol. 2019 Apr 03;10:679. (PMID: 31001277)
Am J Pathol. 2021 Jan;191(1):4-17. (PMID: 32919977)
J Virol. 2006 Jan;80(2):737-49. (PMID: 16378976)
Methods. 2001 Dec;25(4):402-8. (PMID: 11846609)
Biol Proced Online. 2006;8:1-10. (PMID: 16446781)
Front Immunol. 2020 Jan 31;10:3108. (PMID: 32082301)
Int J Cancer. 2003 Oct 10;106(6):879-86. (PMID: 12918065)
PLoS Negl Trop Dis. 2019 May 3;13(5):e0007375. (PMID: 31050676)
Front Immunol. 2019 Dec 13;10:2759. (PMID: 31921102)
Viruses. 2019 Mar 22;11(3):. (PMID: 30909385)
Front Microbiol. 2019 Oct 01;10:2246. (PMID: 31632368)
معلومات مُعتمدة: U01 AI151807 United States AI NIAID NIH HHS
فهرسة مساهمة: Keywords: CCL2 chemokine; CCR2 receptor; Mayaro virus; alphavirus; bone loss; inflammation
المشرفين على المادة: 0 (Chemokine CCL2)
0 (Interleukin-6)
0 (Receptors, CCR2)
0 (Ccl2 protein, mouse)
0 (Ccr2 protein, mouse)
تواريخ الأحداث: Date Created: 20240103 Date Completed: 20240215 Latest Revision: 20240704
رمز التحديث: 20240704
مُعرف محوري في PubMed: PMC10805060
DOI: 10.1128/jvi.01102-23
PMID: 38169294
قاعدة البيانات: MEDLINE